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In a collective effort to find new drugs for killing the ma-
laria parasites (plasmodium) that became resistant to the 
conventional drugs such as chloroquine, scientists in China 
not only rediscovered the anti-malaria effect of the Chinese 
herb Qinghao (Artemesia annua L.), but also isolated the 
single active ingredient Qinghaosu (artemisinin in English) 
in crystal form. They subsequently conducted very system-
atic studies on the pharmacological properties of qinghaosu 
and its derivatives, and determined the unusual chemical 
structure of Qinghaosu. These anti-malaria drugs have 
saved countless lives, especially in the developing coun-
tries. Due to her key role in achieving these remarkable 
discoveries, Prof. Youyou Tu was awarded the 2015 Nobel 
Prize in Physiology or Medicine “for her discoveries con-
cerning a novel therapy against Malaria”. Here I will try to 
tell this fascinating China story based on what have been 
recorded in the peer-reviewed papers that were published in 
Chinese or English and largely in journals published in 
China. 
Malaria has been a devastating infectious disease caused 
by parasites and especially common in the tropical area of 
the world, killing about one million children each year in 
Africa alone (Miller et al., 2013). Scientists in China redis-
covered the anti-malaria effect of the leave extract of the 
Chinese herb Qinghao (English name: Artemisia annua L., 
commonly called the sweet wormwood) in 1971, identified 
Qinghaosu (meaning the “active principle of Qinghao”; 
later translated as “artemisinin” in English) as the active 
principle in 1972, characterized its full chemical and 
three-dimensional structure by 1978, developed more potent 
and also oil or water soluble derivatives in 1979. All these 
remarkable scientific discoveries were achieved within 
about ten years, making an extraordinary and unique China 
story that is worth to be told to the world community (Su 
and Miller, 2015).  
Despite their great power in killing the malaria parasites, 
Qinghaosu derivatives such as the dihydro-qinghaosu, ar-
temether and artesunate, possess a short elimination half-life 
in patients. When used in combination with other types of 
anti-malaria drugs of longer half-life (thus designated as 
Artimesinin-Combination Therapy, or ACT in short), it 
makes the most effective recipe for treating malaria world-
wide and was thus officially recommended by the World 
Health Organization (WHO) (Eastman and Fidock, 2009). 
The development of the qinghaosu family anti-malaria 
drugs undoubtedly represents an outstanding contribution to 
human health. Due to this, Prof. YouYou Tu, as the major 
player in this unique story, was awarded half of the 2015 
Nobel Prize in Physiology or Medicine “for her discoveries 
concerning a novel therapy against Malaria” (and the other 
half to professors William Campbell and Satoshi Omura 
“for their discoveries concerning a novel therapy against 
infections caused by roundworm parasites”).  
The discovery of Qinghaosu and its derivatives as effec-
tive drugs for treating malaria was a result of a collective 
research effort of the so-called “523 Project” organized by 
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the Chinese government, so designated because it was 
started on May 23rd, 1967. The mission of this project was 
to find new drugs for patients who were infected by para-
sites that became resistant to the conventional drugs such as 
chloroquine, involving over 500 scientists from about 60 
institutions all over China. Early research results of this 
project were either not published or published in 
peer-reviewed journals published in China, either in Chi-
nese, or in English, or in both, often in a delayed and unu-
sual manner, such that no names of authors or even no 
names of research institutions listed, except indicating that 
it was contributed by a particular “coordination group”. 
Nevertheless, a systematic retrospective analysis of both the 
published and unpublished records did reveal undoubtedly 
that Prof. YouYou Tu played a key role at most of the stag-
es in this work. Here I will try to tell these amazing discov-
eries according to what were recorded by the peer-reviewed 
papers published in 1970s and early 1980s, and largely in 
journals published in China. But for the descriptions of the 
procedures through which qinghaosu was initially extracted 
and isolated, I have to rely on the book entitled “Qinghao 
and Qinghaosu Family of Drugs” authored by Prof. Tu and 
published in Chinese in 2009, because I could find such 
descriptions nowhere in the peer-reviewed papers published 
(in Chinese or English). 
MALARIA HAS BEEN A DEVASTATING 
PARASITE DISEASE THAT HAS LIKELY 
KILLED ONE HALF OF ALL THE HUMAN 
BEINGS EVER LIVED ON THE EARTH 
The saga of the disease called malaria (meaning ‘bad air’, 
because it was believed to be caused by the miasmas rising 
from the swamps of stagnant water), as characterized by 
intermittent chills and fever, precedes the history of humans 
and has been recorded in the literatures of all the major civi-
lizations since the ancient time. Descriptions of such malar-
ia-specific symptoms are found in ancient Chinese litera-
tures compiled thousands of years ago. Although countless 
ways of treatments were tested over the thousands of years, 
success was occasional and failure was common. Histori-
cally, the epidemic of malaria has been considered as the 
likely cause for the fall of many major powers (including 
the Roman Empire) and defeat in wars. Medical historians 
estimated that malaria has killed around half of all humans 
who have ever lived on the earth!  
The modern elucidation on the cause of malaria  
A scientific understanding of malaria became possible only 
till the end of the 19th century, with the establishment of the 
germ theory of infectious diseases due to the effort of such 
scientists as Louis Pasteur and Robert Kochin1870s. A 
painstaking search for a bacterial cause of malaria in the 
1880s ended with the surprising discovery of the sin-
gle-celled protozoan parasite, belonging to the genus Plas-
modium, as the pathogen. The elucidation of its way of 
transmission was considered as one of the most exciting 
events for humankind to understand infectious diseases.  
The initial breakthrough in identifying the pathogen of 
malaria came from the French army surgeon Alphonse 
Laveran, who, while working in Algeria, observed in 1880 
the parasite in the blood of malarial patients but not in nor-
mal healthy people and immediately realized its relation to 
the disease (Laveran, 1907). Further research by people like 
Patrick Manson, Ronald Ross and others in the 1890s un-
veiled first in birds and then in humans that female mosqui-
toes act as the vector to transmit the malaria parasites from 
one individual to another (Ross and Smyth, 1897; Ross, 
1898; Ross, 1902). Much later, it was discovered first in 
monkeys, remarkably, that the parasites injected by the 
mosquito first live in the human liver cells for about one 
week before moving into the red blood cells, explaining a 
long-puzzled phenomenon that the parasites could only be 
detected in the red blood cells about one week after the 
mosquito biting (Shortt and Garham, 1948).  
Ronald Ross was awarded the 1902 Nobel Prize in 
Physiology or Medicine (http://www.nobelprize.org/nobel_ 
prizes/medicine/laureates/1902/ross-lecture.pdf) “for his 
work on malaria, by which he has shown how it enters the 
organism and thereby has laid the foundation for successful 
research on this disease and methods of combating it.” Al-
phonse Laveran was awarded the 1907 Nobel Prize in 
Physiology or Medicine (http://www.nobelprize.org/nobel_ 
prizes/medicine/laureates/1907/laveran-lecture.html) “in re- 
cognition of his work on the role played by protozoa in 
causing diseases”. 
The unusual life cycle of the malaria parasite 
The malaria parasites possess an unusual life cycle by living 
in both female mosquitos and individuals of human or other 
animals (Thera and Plowe, 2012; Miller et al., 2013; 
Winzeler, 2008), as briefly summarized here (Figure 1). We 
may start from the gut (stomach) of a female mosquito, 
where each Plasmodium oocyst (i.e., encysted zygote) di-
vides to form thousands of sporozoites (i.e., the spores). The 
latter then migrates and infects the mosquito’s salivary 
gland before being injected into the bloodstream of an ani-
mal (or human) individual through biting. The sporozoites 
then start their pre-erythrocyte stage of life by invading the 
victim’s heptocytes (i.e., liver cells), where, after several 
days, they undergo multiple asexual divisions to produce 
merozoites (one sporozoite may develop into many thou-
sands of merozoites). When an infected liver cell bursts, the 
merozoites will be released into the blood and then invade 
the red blood cells (merozoites cannot re-infect other liver 
cells). In the liver cells, some sporozoites may differentiate 
into hypnozoites that remain dormant in the liver for months 
to years before waking up to undergo division and devel-
opment into merozoites (causing the recurrence of the  
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Figure 1 (color online)  The life cycle of the malaria parasites (Plasmo-
dium). 
symptoms in individuals sometime after an effective drug 
treatment of malaria). 
Inside the red blood cells, the merozoites grow and di-
vide asexually into a great number of new merozoites. In 
the red blood cells, themerozoites divide either to form the 
parasite’s sexual form known as gametocyte or the asexual 
form called trophozoite. When the red blood cells rupture, 
which occurs every 48 or 72 hours (depending on the para-
site species), the trophozoites will invade more red blood 
cells, repeating indefinitely, causing the periodic chills and 
fever. The gametocytes from the blood may enter another 
mosquito which bites such an infected patient. Once inside a 
mosquito, the gametocytes will develop into mature sex 
cells, the male and female gametes, which may undergo 
fertilization to form the oocysts again in the gut before di-
viding to form the sporozoites, which may start a new cycle 
of the parasite’s life (Figure 1). 
The malaria parasite’s evasive and complex life cycle 
makes it rather difficult to develop effective vaccines or 
drugs (Thera and Plowe; 2012; Winzeler, 2008; Miller et 
al., 2013). The fact that the malaria parasites spend most of 
their time hiding either inside the liver cells or the red blood 
cells makes it difficult for the host to elicit an efficient im-
mune attack or for scientists to develop an effective vaccine. 
Adding to this difficulty is the genetic mutation occurring 
during the mitotic reproduction in the malaria parasite’s 
haploid stages in the liver and blood, as well as genetic re-
combination during the diploid sexual reproductive stages 
in the mosquito. Both of these generate an extensive genetic 
diversity, such that their surface proteins keep changing 
their “faces”, efficiently escaping the host’s immune attack. 
Another challenge is that some malaria parasites in the liver 
cells may enter a dormant state, towards which drugs be-
come powerless, as true for all types of pathogens that have 
entered their dormant states (Wang et al., 2009; Liu et al., 
2015).   
ANTI-MALARIA DRUGS BEFORE 
QINGHAOSU (ARTEMISININ) 
To the humankind, the first effective drug for treating ma-
laria was the alkaloid-type of compound quinine isolated 
from the bark of cinchona tree. Similar to the story of 
Qinghao, the powdered bark of the cinchona tree was ini-
tially used to treat fever in South America, and then to treat 
malaria in the 17th century. Subsequently, quinine was iso-
lated as the active principle to treat malaria in the 1820s by 
French pharmacists, Pierre-Joseph Pelletier and Jo-
seph-Bienaimé Caventou (Kaufman and Ruveda, 2005). 
Similar to the case of qinghaosu, the action mechanism of 
quinine remains to be defined, one of the explanations is 
that quinine suppresses the biocrystallization and detoxifi-
cation of the heme group in the red blood cells, thus ena-
bling the free and toxic heme groups to accumulate in the 
red blood cells and eventually kill the malaria parasites 
themselves. Apparently, quinine is unable to eradicate the 
malaria disease.  
Quinine was used as the only effective drug against ma-
laria until the 1920s, but resistant strains appeared. In 1934, 
German chemists developed a new anti-malaria quinine 
derivative, chloroquine, which became a dominant an-
ti-malaria drug because it is able to kill several Plasmodium 
species at most stages of the parasite’s life cycle. By the end 
of the Second World War, pharmacists had devised drugs 
effective against parasites at all stages of their life cycles. In 
addition, there was a powerful insecticide called DDT that 
was used to suppress the spread of mosquitos, thus blocking 
them from transmitting the parasite from patients to health 
individuals. 
For a while, it looked as if this combination of mosquito 
control and drug treatment might help the humankind to 
defeat malaria, a disease that has harmed the humankind for 
thousands of years. In 1956, this optimism became the offi-
cial policy of the World Health Organization (WHO), who 
launched a global campaign to eradicate malaria. But in the 
1960s, chloroquine-resistant strains of the parasite and 
DDT-resistant mosquitoes became increasingly common. 
By the end of the 1960s, the WHO had to admit that eradi-
cating malaria was impossible, and switched its goal to con-
trolling the disease.  
QINGHAOSU WAS DISCOVERED AS THE 
ANTI-MALARIA PRINCIPLE PRESENT IN 
THE CHINESE HERB QINGHAO 
It seems to be imperative to develop new drugs once a while 
in order to keep pace with mutations occurring in the ma-
laria parasites. Since the late 1960s, The Chinese govern-
ment started a massive effort to search for new drugs that 
are effective in treating the malaria resistant to such con-
ventional drugs as chloroquine.  One approach was to 
screen the available chemical compound libraries, but ended 
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with no luck. The other approach was to look into the treas-
ure of the traditional Chinese medicine, which，as common 
in scientific research, resulted in at least one success after 
countless failures. Professor YouYou Tu was a key figure in 
this second venture of eventual success.  
Qinghao extract only when prepared in a proper way 
was effective in treating malaria    
Although Qinghao has been recorded in Chinese medical 
books compiled about 1500 years ago for its effectiveness 
in treating malaria, those early practices were based on ex-
periences instead of strict scientific tests. Its therapeutic 
efficacy was unavoidably neither consistent nor pro-
nounced. Prof. YouYou Tu studied modern medicine in 
Beijing Medical College, which was Peking University 
Medical School when she enrolled in 1951, and one year 
later in 1952, it became an independent medical college and 
later a medical university, which was reincorporated into 
Peking University in 2000 and is currently Peking Univer-
sity Health Science Center. After graduation from college, 
Tu was chosen to study Chinese medicine for two full years. 
This allowed her to make the unique contribution in redis-
covering the anti-malaria effect of the Chinese herb 
Qinghao and subsequently isolate the active principle. This 
all started with her deeper understanding on the sentence 
“take one bunch of Qinghao, soak in two sheng (~0.4 liter) 
of water, wring it out to obtain the juice and ingest it in its 
entirety” from a Chinese medical book compiled about 1500 
years ago. She realized that, in contrast to the way of pre-
paring most Chinese medicine which commonly requires 
boiling, in preparing Qinghao extract for treating malaria, 
boiling should be avoided instead (Klayman, 1985; Miller 
and Su, 2011; White, 2008; Tu, 2011). 
The group led by Prof. Tu then painstakingly tried to ex-
tract the active anti-malaria components in Qinghao. For 
this, they tested various solvents (including water, oil, al-
cohol and diethyl ether), different temperatures, different 
parts of the plant, the plant of different developing stages, 
etc (Tu, 2009). As a result, they demonstrated that the effec-
tive components are mainly found in the leaves of mature 
plants and can be effectively extracted with diethyl ether or 
alcohol as solvent but have to  operate at a temperature 
below 60oC (Tu, 2009; Miller and Su, 2011; Su and Miller, 
2015). Interestingly, the active anti-malaria components 
after such diethyl ether or alcohol extraction were found to 
be rather stable, with the anti-malaria activity almost unal-
tered even after being boiled for 30 minutes. It awaits fur-
ther clarification on why heating on the initial mixture de-
stroyed but heating on the solvent-extracted mixture did not 
affect the anti-malaria activity.   
Those components that exhibit toxicity but no an-
ti-malaria activity could be effectively removed by a so-
dium hydroxide extraction step 
In an attempt to reduce the toxicity of the diethyl ether ex-
tract of Qinghao, Tu et al. tried to further separate the active 
ingredients from those inactive components. For that, they 
found, in 1971, that treating the diethyl ether extract of 
Qinghao (active but toxic) with 2% NaOH removed those 
acidic components that are toxic but exhibiting no an-
ti-malaria effect, while the leftover neutral part in the dieth-
yl ether solvent was found to exhibit little toxicity but high 
anti-malaria activity (Tu, 2009; Miller and Su, 2011; Su and 
Miller, 2015). This fraction with high anti-malaria activity 
was again concentrated before being utilized for further 
purification of the active ingredient. 
Qinghaosu was successfully purified as a single crystal-
lizable ingredient by using silica gel column chromatog-
raphy 
The concentrated sample of the Qinghao extract that exhib-
ited high anti-malaria activity but little toxicity was then 
used for further purification of the active ingredients. For 
this purpose, polyamide was first added into this concen-
trated extractum, being shaken by votexing, before perco-
lated with 47% alcohol. The diluted alcohol percolated ex-
tract was then subject to another round of diethyl ether ex-
traction, with the extracted components being separated by 
silica gel column chromatography. The fraction eluted with 
10% acetyl ester from the silicon column was able to form 
needle-like crystals and exhibited the full anti-malaria activ-
ity when tested with mice of malaria, while those eluted 
with other petroleum ether or 15% acetyl ester did not show 
any anti-malaria activity (Tu, 2009). 
The systematic data of the anti-malaria activity of 
Qinghaosu was first published in 1979 
Although Qinghaosu was first isolated in crystal form as the 
active anti-malaria ingredient in 1972 (by Prof. Tu et al.) 
and systematic structural and pharmacological studies were 
performed since then, the publication of these novel re-
search data was years delayed. The first paper on Qinghaosu 
was published in 1977, but only reporting its structure, 
without mentioning anything about its anti-malaria activity 
(Qinghaosu Coordinating Research Group, 1977). The two 
papers (they were actually one paper published in Chinese 
and English) reporting about the anti-malaria activity of 
Qinghaosu were published two years later (Qinghaosu An-
timalaria Coordinating Research Group, 1979a, 1979b].  
Although there was no description in these early papers 
and others published later on how Qinghaosu was isolated, 
its chemical structure, its efficacy in treating animal (mice, 
monkey, chicken) malaria, its toxicity, its clinical trial re-
sults (among the 2,099 malaria patients tested from all over 
China between 19731978, covering all types of malaria 
including choroquine-resistant and brain malaria, all were 
effective except about 10 people who died due to other 
complications) and its pharmacokinetics (absorption, organ 
distribution, biotransformation and excretion, by adminis-
tering radio-labeled Qinghaosu to the animals)，one-month 
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recrudescent rate were all described in detail (Qinghaosu 
Antimalaria Coordinating Research Group, 1979a, 1979b; 
China Cooperative Research Group on Qinghaosu and Its 
Derivatives as Antimalarials, 1982a, b, c, d, e, f). These 
results demonstrated that Qinghaosu is an anti-malaria drug 
of rapid action, high efficiency and low toxicity but also of 
a short elimination half-life in the body and a rather high 
one-month recrudescence rate after a three-day treatment.  
Remarkably, Qinghaosu apparently cleared the parasite 
from the blood and relieved the fever symptoms within a 
time period that was significantly shorter than chloroquine 
did in addition to its efficiency in curing cerebral and chlo-
roquine-resistant malaria. Further analysis demonstrated 
that Qinghaosu exhibited direct killing effect only on the 
parasites living in erythrocytes but not on those living the 
heptocytes. Studies with electron microscopy revealed that 
Qinghaosu apparently directly damaged the membrane sys-
tem in the parasite cell, leading to the formation of au-
tophagic vacuoles and eventual death of the parasites 
(QinghaosuAntimalaria Coordinating Research Group, 
1979a, 1979b; Tu, 2009; Zhou, 2015). The recrudescent 
parasites were apparently generated from those dormant 
forms of the parasites hiding in the liver cells, instead of due 
to any mutations of the parasite. In view of these advantages 
and disadvantages of Qinghaosu (or its derivatives) treat-
ment, WHO suggested admisinin combination therapy 
(ACT) as a standard treatment for malaria, with an addi-
tional drug of longer elimination half-life being used to-
gether with Qinghaosu. The practice of ACT has signifi-
cantly lowered the recrudescent rate of Qinghaosu. 
QINGHAOSU POSSESSES AN UNUSUAL 
MULTI-RING AND NITROGEN-FREE 
CHEMICAL STRUCTURE 
The first publication on Qinghaosu focused on its unique 
structure (Qinghaosu Coordinating Research Group, 1977) 
(the manuscript was submitted on Feb. 20, 1976). “The 
Qinghaosu Structure Study Coordinating Group” was listed 
as the “author”, with names of neither authors nor institu-
tions indicated. Although there was no description on how 
this material named as Qinghaosu was isolated (except in-
dicating that it was a colorless crystalline isolated from the 
plant Qinghao, its chemical structure was claimed to be 
comprehensively examined using all types of modern tech-
niques). 
Qinghaosu was characterized as a new type of sesquit-
erpene lactone containing a key peroxide group 
Through comprehensive chemical and physical analyses, it 
was demonstrated that Qinghaosu is a new type of sesquit-
erpene lactone (meaning that the molecule contains three 
molecules of isoprene units and a lactone ring). It differs 
from another sesquiterpene lactone that was recently isolat-
ed from Artimisia Annua L. (named as arteannuin B, with a 
molecular formula of C15H20O3 (Jeremic et al., 1973)) by 
containing an additional unique peroxide group (Qinghaosu 
Coordinating Research Group, 1977; China Cooperative 
Research Group on Qinghaosu and Its Derivatives as Anti-
malarials, 1982a). In these characterizations on Qinghaosu, 
types of methods used include element analysis, high reso-  
 
 
Figure 2  Structure of Qinghaosu (artemisinin), dihydro-qinghaosu, artemether, artesunate and quinine. 
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lution mass spectrometry, infrared spectroscopy, 1H and 13C 
NMR (with almost all the different types of hydrogen atoms 
and all the 15 carbon atoms clearly identified using a 100 
MHz machine), chemical reaction analysis and X-ray crys-
tallography, and others. The properties of this molecule 
were characterized as possessing a melting point of 
156157°C, an optical activity of +66.3°, a molecular for-
mula of C15H22O5, a lactone (i.e., with an IR absorption 
peak at 1745 cm1) and a peroxide group (i.e., with IR ab-
sorption peaks at 831, 881 and 1115 cm1), but containing 
no carbon-carbon double bond (Qinghaosu Coordinating 
Research Group, 1977; Liu et al., 1979; China Cooperative 
Research Group on Qinghaosu and Its Derivatives as Anti-
malarials, 1982a).Although the three-dimen- sional struc-
ture of Qinghaosu was displayed and described in these 
early papers (Qinghaosu Coordinating Research Group, 
1977; Qinghaosu Antimalaria Coordinating Research 
Group, 1979a; Qinghaosu Antimalaria Coordinating Re-
search Group, 1979b), detail reports on the X-ray crystal-
lography studies on Qinghaosu appeared later (see below).  
The three dimensional structure of Qinghaosu was de-
termined by X-ray crystallography    
The X-ray single crystal diffraction studies, with the crys-
tals provided by the Qinghao Research Group of the Insti-
tute of Chinese Materia Medica, Academy of Traditional 
Chinese Medicine, elucidated the three dimensional struc-
ture of the Qinghaosu molecule, including the absolute con-
figuration of the 7 asymmetric carbons (Qinghaosu Re-
search Group of the Institute of Biophysics of the Chinese 
Academy of Sciences, 1979; 1980; both papers had the 
identical contents, but the former was published in Chinese 
and the latter in English, and both submitted on May 9, 
1978). In this work, the diffraction studies were performed 
using a four-circle diffractometer PW-1100 (using CuKa 
radiation). The structure was resolved by the symbolic addi-
tion procedure and refined by full-matrix least-square 
method to a final R index of 0.085 for 1553 reflections and 
0.074 for 1299 observed reflections. The absolute configu-
rations of all the asymmetric carbons in the Qinghaosu 
molecule were determined. It was revealed that the 15 car-
bon atoms and 5 oxygen atoms in the Qinghaosu molecule 
are linked into a structure of four rings (designated as ring 
A, B, C or D；as displayed in Figure 2). In particular, ring A 
is a chair-shaped cyclohexane, rings B and C are both satu-
rated oxyheterocycles, while ring D is a delta-lactone (i.e., 
an intra-molecular ester). Remarkably, all the five oxygen 
atoms are allocated on one side of the molecule (Figure 2) 
forming a unique carbon-oxygen chain (made of O-C12-O- 
C5-O-C4-O-O-C6). Apparently, this unique carbon-oxygen 
chain makes the peroxide group unusually stable towards 
both heat and light. How the unique chemical properties of 
this chain of carbon-oxygen enable Qinghaosu to exhibit the 
anti-malaria activity remains to be clarified. 
DIHYDRO-QINGHAOSU AND OTHER 
DERIVATIVES OF QINGHAOSU WERE 
FOUND TO EXHIBIT A MORE POTENT 
ANTI-MALARIA EFFECT THAN QINGHAOSU 
Such undesired properties as low water solubility and high 
recrudescence rate of Qinghaosu prompted scientists in 
China to try to develop derivatives of Qinghaosu (as simi-
larly done on quinine). For this, they found that treating 
Qinghaosu with sodium borohydride (NaBH4) generated 
dihydro-qinghaosu (whose structure is shown in Figure 2). 
This resulted in the reduction of the only carbonyl group in 
the Qinghaosu molecule to a hydroxyl group, to which (and 
only to which) many chemical groups were subsequently 
covalently linked, generating a great number of derivatives 
that included ethers, esters and carbonates (Li et al., 1979; 
China Cooperative Research Group on Qinghaosu and its 
Derivatives as Antimalarials, 1982b). When applied to treat 
mice infected with chloroquine resistant P. berghei, dihy-
dro-qinghaosu and many of these dihydro-qinghaosu deriv-
atives were found to exhibit a much more potent an-
ti-malaria effect than Qinghaosu itself (Gu et al., 1980; 
China Cooperative Research Group on Qinghaosu and Its 
Derivatives as Antimalarials, 1982c). These studies mean-
while demonstrated that the peroxide group in Qinghaosu 
has to be maintained for any derivative to exhibit an an-
ti-malaria effect. In other words, the peroxide group is es-
sential for Qinghaosu to exhibit the anti-malaria effect (Gu 
et al., 1980). Among these synthesized and tested Qingha-
osu derivatives were those that were developed into com-
monly used anti-malaria drugs, such as artemether (Figure 
2; i.e., having a methyl group linked to the hydroxyl group, 
thus of high oil solubility, and thus proper for oral admin-
istration) (Gu et al., 1980, 1981; China Cooperative Re-
search group on Qinghaosu and Its Derivatives as Antima-
larials, 1982b, 1982c, 1982f). Another derivative of high 
water solubility and anti-malaria efficiency is artesunate 
(Figure 2; i.e., having a succinate linked in its monoester-
form, thus of high water solubility and proper for intrave-
nous injection) (China Cooperative Research group on 
Qinghaosu and Its Derivatives as Antimalarials, 1982b, 
1982c, 1982f). 
THE OUTSIDE WORLD LEARNED AND 
CONFIRMED THE ANTI-MALARIA EFFECT 
OF QINGHAOSU (ARTEMISININ) 
Although the chemical structure of Qinghaosu was first 
published in 1977 (Qinghaosu Coordinating Research 
Group, 1977), its anti-malaria effect was first announced to 
the general public (including in China) only in papers pub-
lished two years later (Qinghaosu Antimalaria Coordinating 
Research Group, 1979, 1979b)，it immediately caused the 
attention of the outside world. Two more years later, WHO, 
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together with the United Nations Development Program and 
World Bank, organized a special conference “the Fourth 
Meeting of the Scientific Working Group on the Chemo-
therapy of Malaria”, October 610, 1981 in Beijing (The 4th 
meeting of the SWG-CHEMAL, 1981; Bruce-Chwatt, 1982; 
Klayman, 1985; Miller and Su, 2011; Tu, 2011). Qingha-
osu’s outstanding anti-malaria activity and unusual nitro-
gen-free chemical structure, all unveiled for the first time 
and completely characterized by scientists in China during a 
chaotic period of time (i.e., the so-called Culture Revolu-
tion), were intriguing (or even shocking) to the outside 
world (Bruce-Chwatt, 1982; Klayman, 1985; White, 2008; 
Miller and Su, 2011). The correctness of such a hitherto 
unknown unique structure was further proved by its full 
chemical synthesis. This outstanding work was painstak-
ingly and almost simultaneously accomplished by scientists 
both in China (Xu et al., 1983) and in Switzland (Schmid 
and Hofheinz, 1983). Nevertheless, such chemical synthesis 
procedures remain too complex and  too expensive for 
producing Qinghaosu this way for commercial applications 
(in other words, we have to still rely on the plant Qinghao to 
produce Qinghaosu for us). 
When the Chinese scientists developed artemether (for 
oral administration) and artesunate (for intravenous injec-
tion) as the common anti-malaria drug (Gu et al., 1980, 
1981; China Cooperative Research Group on Qinghaosu 
and Its Derivatives as Antimalarials, 1982c), it was almost 
entirely ignored outside China. Nevertheless, on the one 
hand, the situation of parasite resistance to the available 
anti-malaria drugs (e.g., quinine, chloroquine and meflo-
quine) was worsening, and on the other hand, the accumu-
lating evidences supported the rapidity, reliability and safety 
of the Qinghaosu family drugs. These facts forced col-
leagues outside China to change their mind and switched to 
the drugs discovered and developed by scientists in China 
(Klayman, 1985; White, 2008; Miller and Su, 2011). The 
first non-Chinese journal that reported about the better an-
ti-malaria efficacy of Qinghaosu over the conventional 
drugs was Lancet (Jiang et al., 1982). Revelations on the 
outstanding anti-malaria effect of Qinghaosu was later con-
firmed by scientists in the United States (Klayman et al., 
1984). After these, Qinghaosu and its derivatives (including 
dihydro-qinghaosu, artemether, artesunate and others) be-
came first choice anti-malaria drugs by physicians world-
wide (Bruce-Chwatt, 1982; Klayman, 1985; White, 2008; 
Miller and Su, 2011). 
SUMMARY AND PERSPECTIVES 
The discovery of the anti-malaria effect of the Chinese herb 
Qinghao had been a long and tortuous China story, in which 
scientists in China initially extracted the active mixture and 
subsequently purified the active ingredient Qinghaosu, 
characterized the unusual structure of Qinghaosu, prepared 
derivatives that retain the anti-malaria effect but are more 
potent in eliminating the parasite and more convenient for 
administration to the patients (i.e., soluble either in water or 
oil), among others. The discovery of Qinghaosu as an an-
ti-malaria drug that is more effective than the other drugs, 
and importantly more efficient in killing the malaria para-
sites that have become resistant to the other drugs repre-
sented a major contribution of scientists in China to the 
world. We expect more such treasures to be dug out from 
the Chinese traditional medicine, which has a recorded his-
tory of thousands of years.  
As usual in scientific research, many questions remain on 
Qinghaosu and its derivatives. For example, what they exact 
do in killing the parasites (Zhou, 2015)? Why do they ex-
hibit a killing effect only on the parasites living in the red 
blood cells but exhibit no effect on the parasite living in the 
liver cells? Why do the plants synthesize such an unusual 
molecule by spending much energy and via a multistep bi-
osynthetic pathway? What does it do for the plants? Do 
plants other than Qinghao also synthesize it and again for 
what purposes (If Qinghaosu is synthesized in other plants, 
it should play role similar as in Qinghao)? 
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